Latest Form 4 insider transactions

Cary D Mcmillan, a Director of American Eagle Outfitters Inc, sold 3,617 shares of common stock on October 6, 2026 for $18.20 per share.

Eric Vishria, a Director of Cerebras Systems Inc., reported a transaction in 59,126 shares of common stock on October 5, 2026.

Renee D Gala, President & CEO and a Director of Jazz Pharmaceuticals plc, sold 2,000 shares of common stock on October 6, 2026 for $236.40 per share.

AJB Investment Fund II, LP and 3 others reported changes in beneficial ownership of Jewett Cameron Trading Co Ltd common stock on October 5, 2026.

Nikolas W Stengle, Chief Executive Officer and a Director of Brookdale Senior Living Inc., reported a transaction in 20,677 shares of common stock on October 6, 2026.

Norman P Taffe, President Generac Home of Generac Holdings Inc., sold 550 shares of common stock on October 5, 2026.

Kevin Holleran, President and CEO and a Director of Hayward Holdings, Inc., sold 50,000 shares of common stock on October 5, 2026 for $12.40 per share.

Ynon Kreiz, Co-Chief Executive Officer and a Director of New Pluto Global, Inc., reported multiple transactions in common stock on October 5, 2026.

Robert Joseph Deshaies, COO, Benefits of WEX Inc., sold 2,000 shares of common stock on October 5, 2026.

Judson C Linville, a Director of Alkami Technology, Inc., received 420 shares of common stock on October 5, 2026.

Fernando Lovisotto, Head of Global IP&S of Vinci Partners Investments Ltd., sold 16,993 shares of common stock on October 5, 2026.

Jeffrey H Fox, a Director of Alkami Technology, Inc., received 420 shares of common stock on October 5, 2026.

Maria Ines Alvarez, a Director of Alkami Technology, Inc., received 630 shares of common stock on October 5, 2026.

Mark Elliott Boulding, EXEC. VP AND CLO of Ptc Therapeutics, Inc., sold 2,073 shares of common stock on October 5, 2026.

Richard F Ambrose, a Director of Firefly Aerospace Inc., received 6,716 shares of common stock on October 5, 2026.

Brian R Smith and 3 others reported changes in beneficial ownership of Alkami Technology, Inc. common stock on October 5, 2026.

Steven R Mitchell, a Director of Alkami Technology, Inc., received 490 shares of common stock on October 5, 2026.

Charles Alvin Meloy, a Director of Diamondback Energy, Inc., sold 33,333 shares of common stock on October 5, 2026.

Stephen G Pagliuca, a Director of Coherent Corp., received 279 shares of common stock on February 11, 2026.

Ugur Sahin, Chief Executive Officer and 10% owner of BioNTech SE, sold 24,000 shares of common stock on October 7, 2026 for $95.86 per share.

Charles Collier, President, Roku Media of Roku, Inc, sold 20,538 shares of common stock on October 5, 2026.

David Kirn, See Remarks and a Director of 4D Molecular Therapeutics, Inc., sold 58,333 shares of common stock on October 5, 2026.

Gerald Bartholomew Smith, Chief Executive Officer and a Director of Avalanche Treasury Corp, reported a transaction in 34,369 shares of common stock on October 5, 2026.

Laine Mihalchick Moljo, Chief Operating Officer of Avalanche Treasury Corp, reported a transaction in 15,808 shares of common stock on October 5, 2026.

Michael Stock, Chief Financial Officer of Liberty Energy Inc., sold 3,333 shares of common stock on October 6, 2026 for $20.00 per share.

Jeremy Allaire, Chairman and CEO and a Director of Circle Internet Group, Inc., sold 62,264 shares of common stock on October 5, 2026.

Ivan Brockman, a Director of Vera Bradley, Inc., purchased 10,000 shares of common stock on October 6, 2026 for $5.02 per share.

Medtronic plc is offering to exchange newly issued shares of MiniMed Group, Inc. for its own common stock as part of a strategic restructuring.

Mary Miller, Chief Legal Officer of Acrivon Therapeutics, Inc., sold 294 shares of common stock on October 5, 2026 for $1.99 per share.

Christopher Lee Turner, Chief Executive Officer and a Director of Yum Brands Inc, sold 285 shares of common stock on October 7, 2026 for $140.11 per share.